Melatonin for premenstrual syndrome: A potential remedy but not ready

Premenstrual syndrome (PMS), a recurrent and moderate disorder that occurs during the luteal phase of the menstrual cycle and quickly resolves after menstruation, is characterized by somatic and emotional discomfort that can be severe enough to impair daily activities. Current therapeutic drugs for...

Full description

Bibliographic Details
Main Authors: Wei Yin, Jie Zhang, Yao Guo, Zhibing Wu, Can Diao, Jinhao Sun
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-01-01
Series:Frontiers in Endocrinology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2022.1084249/full
_version_ 1828068435689472000
author Wei Yin
Jie Zhang
Yao Guo
Zhibing Wu
Can Diao
Jinhao Sun
author_facet Wei Yin
Jie Zhang
Yao Guo
Zhibing Wu
Can Diao
Jinhao Sun
author_sort Wei Yin
collection DOAJ
description Premenstrual syndrome (PMS), a recurrent and moderate disorder that occurs during the luteal phase of the menstrual cycle and quickly resolves after menstruation, is characterized by somatic and emotional discomfort that can be severe enough to impair daily activities. Current therapeutic drugs for PMS such as selective serotonin reuptake inhibitors are not very satisfying. As a critical pineal hormone, melatonin has increasingly been suggested to modulate PMS symptoms. In this review, we update the latest progress on PMS-induced sleep disturbance, mood changes, and cognitive impairment and provide possible pathways by which melatonin attenuates these symptoms. Moreover, we focus on the role of melatonin in PMS molecular mechanisms. Herein, we show that melatonin can regulate ovarian estrogen and progesterone, of which cyclic fluctuations contribute to PMS pathogenesis. Melatonin also modulates gamma-aminobutyric acid and the brain-derived neurotrophic factor system in PMS. Interpreting the role of melatonin in PMS is not only informative to clarify PMS etiology but also instructive to melatonin and its receptor agonist application to promote female health. As a safe interaction, melatonin treatment can be effective in alleviating symptoms of PMS. However, symptoms such as sleep disturbance, depressive mood, cognitive impairment are not specific and can be easily misdiagnosed. Connections between melatonin receptor, ovarian steroid dysfunction, and PMS are not consistent among past studies. Before final conclusions are drawn, more well-organized and rigorous studies are recommended.
first_indexed 2024-04-11T00:02:53Z
format Article
id doaj.art-02c19731bde14ee08dd45132290b80c4
institution Directory Open Access Journal
issn 1664-2392
language English
last_indexed 2024-04-11T00:02:53Z
publishDate 2023-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Endocrinology
spelling doaj.art-02c19731bde14ee08dd45132290b80c42023-01-09T14:35:28ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922023-01-011310.3389/fendo.2022.10842491084249Melatonin for premenstrual syndrome: A potential remedy but not readyWei Yin0Jie Zhang1Yao Guo2Zhibing Wu3Can Diao4Jinhao Sun5Shandong Key Laboratory of Mental Disorders, Department of Anatomy and Neurobiology, Shandong University, Jinan, Shandong, ChinaDepartment of Neurosurgery, Laizhou City People’s Hospital, Laizhou, Shandong, ChinaDepartment of Psychiatry, Shandong Provincial Mental Health Center, Jinan, Shandong, ChinaDepartment of Anatomy, Changzhi Medical College, Changzhi, Shanxi, ChinaSchool of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, ChinaShandong Key Laboratory of Mental Disorders, Department of Anatomy and Neurobiology, Shandong University, Jinan, Shandong, ChinaPremenstrual syndrome (PMS), a recurrent and moderate disorder that occurs during the luteal phase of the menstrual cycle and quickly resolves after menstruation, is characterized by somatic and emotional discomfort that can be severe enough to impair daily activities. Current therapeutic drugs for PMS such as selective serotonin reuptake inhibitors are not very satisfying. As a critical pineal hormone, melatonin has increasingly been suggested to modulate PMS symptoms. In this review, we update the latest progress on PMS-induced sleep disturbance, mood changes, and cognitive impairment and provide possible pathways by which melatonin attenuates these symptoms. Moreover, we focus on the role of melatonin in PMS molecular mechanisms. Herein, we show that melatonin can regulate ovarian estrogen and progesterone, of which cyclic fluctuations contribute to PMS pathogenesis. Melatonin also modulates gamma-aminobutyric acid and the brain-derived neurotrophic factor system in PMS. Interpreting the role of melatonin in PMS is not only informative to clarify PMS etiology but also instructive to melatonin and its receptor agonist application to promote female health. As a safe interaction, melatonin treatment can be effective in alleviating symptoms of PMS. However, symptoms such as sleep disturbance, depressive mood, cognitive impairment are not specific and can be easily misdiagnosed. Connections between melatonin receptor, ovarian steroid dysfunction, and PMS are not consistent among past studies. Before final conclusions are drawn, more well-organized and rigorous studies are recommended.https://www.frontiersin.org/articles/10.3389/fendo.2022.1084249/fullmelatoninpremenstrual syndromecircadian rhythmsovarian steroidcognitiongamma-aminobutyric acid
spellingShingle Wei Yin
Jie Zhang
Yao Guo
Zhibing Wu
Can Diao
Jinhao Sun
Melatonin for premenstrual syndrome: A potential remedy but not ready
Frontiers in Endocrinology
melatonin
premenstrual syndrome
circadian rhythms
ovarian steroid
cognition
gamma-aminobutyric acid
title Melatonin for premenstrual syndrome: A potential remedy but not ready
title_full Melatonin for premenstrual syndrome: A potential remedy but not ready
title_fullStr Melatonin for premenstrual syndrome: A potential remedy but not ready
title_full_unstemmed Melatonin for premenstrual syndrome: A potential remedy but not ready
title_short Melatonin for premenstrual syndrome: A potential remedy but not ready
title_sort melatonin for premenstrual syndrome a potential remedy but not ready
topic melatonin
premenstrual syndrome
circadian rhythms
ovarian steroid
cognition
gamma-aminobutyric acid
url https://www.frontiersin.org/articles/10.3389/fendo.2022.1084249/full
work_keys_str_mv AT weiyin melatoninforpremenstrualsyndromeapotentialremedybutnotready
AT jiezhang melatoninforpremenstrualsyndromeapotentialremedybutnotready
AT yaoguo melatoninforpremenstrualsyndromeapotentialremedybutnotready
AT zhibingwu melatoninforpremenstrualsyndromeapotentialremedybutnotready
AT candiao melatoninforpremenstrualsyndromeapotentialremedybutnotready
AT jinhaosun melatoninforpremenstrualsyndromeapotentialremedybutnotready